Cargando…
Species-Specific Inactivation of Triosephosphate Isomerase from Trypanosoma brucei: Kinetic and Molecular Dynamics Studies
Human African Trypanosomiasis (HAT), a disease that provokes 2184 new cases a year in Sub-Saharan Africa, is caused by Trypanosoma brucei. Current treatments are limited, highly toxic, and parasite strains resistant to them are emerging. Therefore, there is an urgency to find new drugs against HAT....
Autores principales: | Vázquez-Raygoza, Alejandra, Cano-González, Lucia, Velázquez-Martínez, Israel, Trejo-Soto, Pedro Josué, Castillo, Rafael, Hernández-Campos, Alicia, Hernández-Luis, Francisco, Oria-Hernández, Jesús, Castillo-Villanueva, Adriana, Avitia-Domínguez, Claudia, Sierra-Campos, Erick, Valdez-Solana, Mónica, Téllez-Valencia, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149853/ https://www.ncbi.nlm.nih.gov/pubmed/29186784 http://dx.doi.org/10.3390/molecules22122055 |
Ejemplares similares
-
Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential
por: Castillo-Villanueva, Adriana, et al.
Publicado: (2017) -
Repurposing of rabeprazole as an anti-Trypanosoma cruzi drug that targets cellular triosephosphate isomerase
por: García-Torres, Itzhel, et al.
Publicado: (2023) -
Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century
por: Campos-Almazán, Mara Ibeth, et al.
Publicado: (2022) -
Structural Effects of Protein Aging: Terminal Marking by Deamidation in Human Triosephosphate Isomerase
por: de la Mora-de la Mora, Ignacio, et al.
Publicado: (2015) -
Structural and Functional Perturbation of Giardia lamblia Triosephosphate Isomerase by Modification of a Non-Catalytic, Non-Conserved Region
por: Hernández-Alcántara, Gloria, et al.
Publicado: (2013)